Every year, cancer is responsible for millions of deaths worldwide and, even though much
progress has been achieved in medicine, there are still many issues that must be addressed …

Patients treated with conventional cancer chemotherapy suffer from side effects of the drugs
due to non-selective action of chemotherapeutic drugs to normal cells. Active targeting …

Despite enormous development in the field of drug development, cancer still remains
elusive. Compromised immunity stands as a roadblock to the successful pharmacological …

As far as health issues are concerned, cancer causes one out of every six deaths around the
globe. As potent therapeutics are still awaited for the successful treatment of cancer, some …

Approximately 20% of breast cancer cases are human epidermal growth factor receptor 2
(HER2)-positive. This type of breast cancer is more aggressive and tends to reoccur more …

Nanomaterials, like nanoparticles, micelles, nano-sheets, nanotubes and quantum dots,
have great potentials in biomedical fields. However, their delivery is highly limited by the …

Human beings are “machines” that use endogenously produced biomolecules as
“components” in signaling and for the maintenance of the body. These biomolecules consist …

Introduction: Despite remarkable advances in tumor treatment, many patients still die from
common tumors (breast, prostate, lung, CNS, colon, and pancreas), and thus, new …

Fisetin (FST), a potent anticancer phytoconstituent, exhibits poor aqueous solubility and
hence poor bioavailability. The aim of the present study is to improve the oral bioavailability …

Cyclodextrins possess the ability to increase the apparent solubility and dissolution rate of
poorly water soluble drugs. The objectives of the study were to investigate the effect of β …